SeaStar Medical Holding Corp
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
ICU$1.90-3.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (September 30, 2025 Unaudited)
Condensed Consolidated Balance Sheets
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| (unaudited) | ||
| ASSETS | ||
| Current assets | ||
| Cash | $13,763 | $1,819 |
| Accounts receivable, net of allowance for credit losses of $7 and $0, respectively | 221 | 112 |
| Inventory | 83 | — |
| Prepaid expenses | 807 | 1,835 |
| Total current assets | 14,874 | 3,766 |
| Other assets | 656 | 892 |
| Total assets | $15,530 | $4,658 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY/(DEFICIT) | ||
| Current liabilities | ||
| Accounts payable | $2,018 | $3,046 |
| Accrued expenses | 2,047 | 3,188 |
| Notes payable, net of deferred financing costs | — | 574 |
| Liability classified warrants | 1 | 33 |
| Total current liabilities | 4,066 | 6,841 |
| Total liabilities | 4,066 | 6,841 |
| Commitments and contingencies (Note 10) | ||
| Stockholders’ equity/(deficit) | ||
| Preferred stock - $0.0001 par value, 10,000,000 shares authorized at September 30, 2025 and December 31, 2024; no shares issued and outstanding at September 30, 2025 and December 31, 2024 | — | — |
| Common stock - $0.0001 par value per share; 450,000,000 and 500,000,000 shares authorized at September 30, 2025 and December 31, 2024, respectively; 34,096,420 and 5,977,246 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 3 | 2 |
| Additional paid-in capital | 160,271 | 137,379 |
| Accumulated deficit | (148,810) | (139,564) |
| Total stockholders’ equity/(deficit) | 11,464 | (2,183) |
| Total liabilities and stockholders’ equity/(deficit) | $15,530 | $4,658 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.